Gavin Preston, PhD

Consultant Haematologist
Aberdeen Royal Infirmary, United Kingdom

Dr Gavin Preston
BSc, MBBS, PhD, MRCP, FRCPath
Consultant Haematologist, Aberdeen Royal Infirmary

Poster(s):

• 1433 - Ibrutinib plus venetoclax with measurable residual disease-guided duration of treatment is superior to both ibrutinib monotherapy and fludarabine-cyclophosphamide-rituximab for previously untreated chronic lymphocytic leukaemia: Report of the Phase III UK NCRI FLAIR study.